The influx of PE investment in drug development is 'great evidence of the need for capital solutions for the life sciences,' said NovaQuest’s Patrick Jordan.
PE spots opportunities in horses healthcare: 5 deals
22 hours ago · 3 mins read
Blackstone spots AI and low-cost interceptors opportunity with Falcata defense platform
21 October 2026 · 2 mins read
Exclusive: MSCP bets on aging water infrastructure with The Rapid Group investment
20 October 2026 · 3 mins read
PE eyes cardiometabolic care amid GLP-1 boom, outpatient shifts: 6 deals
16 October 2026 · 3 mins read
Exclusive: Vista agrees to acquire HID's PKI business unit
16 October 2026 · 3 mins read
ArchiMed’s Denis Ribon details €1.5bn fund deployment plans as AI reshapes healthcare
14 October 2026 · 4 mins read
Exclusive: ATL Partners forms Precise Aerospace & Defense platform
13 October 2026 · 3 mins read
